breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with breast cancer diagnosed by pathology. 2.Patients who have undergone radical mastectomy. 3.Did not receive radiotherapy, chemotherapy or any other drugs that affect immune function before surgery. 4.No other tumors, acute or chronic inflammations, blood system diseases and autoimmune diseases. 5.Age 18–80 years, female gender. 6.ECOG PS of 0-2, life expectancy >= 3 months. 7.With normal bone marrow, heart, liver and kidney functions. 8.Ability to understand and the willingness to sign a written informed consent document, capable of providing responses during outcome measurement.
Exclusion criteria
Exclusion criteria: 1.History of other malignant tumors within 5 years. 2.Patients with active autoimmune disease. 3.Active infection, including active tuberculosis infection. 4.Severe infection after surgery. 5.Radiotherapy, chemotherapy, acupuncture, press needle or drugs that affect immune function received within the past 4 weeks. 6.Life expectancy < 3 months. 7.Comorbidities such as serious heart, kidney, or liver diseases. 8.Pregnancy or currently lactating(including patients of reproductive age who do not want to use contraception); severe mental disorders such as cognitive impairment. 9.Refusal to accept press needle. 10.Participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of (CD8 +) T cells in peripheral blood;The proportion of (CD4 +) T cells in peripheral blood;The proportion of (CD3 +) T cells in peripheral blood;The proportion of (CD4 + / CD8 +) T cells in peripheral blood; | — |
Secondary
| Measure | Time frame |
|---|---|
| KPS score;EORTC QLQ-C30 score; | — |
Countries
China
Contacts
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine